Pular para o conteúdo
PodcastsCiênciaFreely Filtered, a NephJC Podcast

Freely Filtered, a NephJC Podcast

NephJC Team
Freely Filtered, a NephJC Podcast
Último episódio

100 episódios

  • Freely Filtered, a NephJC Podcast

    FF97 MERCURI-2, Can a Flozin prevent AKI?

    27/09/2026 | 1h 20min
    Bypass surgery continues to be the laboratory where we test the most innovative ideas on the prevention of AKI
    The Filtrate
    Joel Topf @kidney_boy
    Swapnil Hiremath @hswapnil.medsky.social
    Vipin Varghese
    Sophia Ambruso
    Special Guests
    Rahul Ganatra Deputy Editor NEJM Clinician. https://clinician.nejm.org/editors/AU3406
    Jay Koyner Professor of Medicine, University of Chicago. https://www.uchicagomedicine.org/find-a-physician/physician/jay-koyner

    Editing
    Vipin Varghese
    The Kidney Connection written and performed by Timothy Yau

    Show Notes
    Back to the Future: https://youtu.be/BDuZqYeNiOA?is=r-RE2DgIDBazRAlW
    Amino Acids for AKI: The PROTECTION Study NephJC: Trial by Combat: Do Amino Acids provide PROTECTION to the Kidneys?
    In 2016 the FDA posted a warning that SGLT2i could induce AKI. This Nature Reviews Nephrology explores possible mechanisms for the AKI: Acute kidney injury from SGLT2 inhibitors: potential mechanisms https://www.nature.com/articles/nrneph.2016.159
    But by 2019 the SMART-C Collaboration was looking at the risk of AKI in the large RCTs and found Flozins to be protective: SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30256-6/abstract
    If you are actually looking for the best data you should look at the updated meta-analysis from 2025 which extends the findings to patients with and without diabetes and to patients with and without CKD: SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria https://pmc.ncbi.nlm.nih.gov/articles/PMC12595549/
    2012 KDIGO AKI Guidelines: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf
    The 2025/2026 AKI Draft guidelines: https://kdigo.org/wp-content/uploads/2026/03/KDIGO-2026-AKI-AKD-Guideline-Public-Review-Draft-March-2026.pdf
    Meta-analysis of frusemide to prevent or treat acute renal failure https://www.bmj.com/content/early/2005/12/31/bmj.38902.605347.7C

    Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition https://diabetesjournals.org/care/article-abstract/38/9/1687/37246/Euglycemic-Diabetic-Ketoacidosis-A-Potential
    Topic of this podcast, the MERCURI-2 trial: Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery https://jamanetwork.com/journals/jama/article-abstract/2852324 | NephJC: Too sweet to be true? Prophylactic SGLT2 inhibitors before cardiac surgery https://www.nephjc.com/news/2026/8/18/mercuri2
    MERCURI-1 Pilot trial is described here. Looks like it was only published as a pre-print. The first link provides a glimpse at MERCURI-3
    https://abrahamhulst.com/research/mercuri-1/
    https://www.medrxiv.org/content/10.1101/2024.03.27.24304998v1.full.pdf
    Vipin Varghese used to believe in the urinalysis: Diagnostic Utility of Serial Microscopic Examination of the Urinary Sediment in Acute Kidney Injury https://pubmed.ncbi.nlm.nih.gov/35373012/
    MERCURI-2 in ClinicalsTrials.gov: proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2 (MERCURI-2) https://clinicaltrials.gov/study/NCT05590143
    Roger Rodby’s 4 favortite equations in Nephrology from Channel Your Enthusioasm: https://pca.st/episode/abff985f-6a87-41f9-bcc9-80b8a85c2441?t=3257.0
    IDEAL ICU Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis https://www.nejm.org/doi/full/10.1056/NEJMoa1803213?referrer=https%3A%2F%2Fwww.google.com%2F
    Rethinking the definition of oliguria: Identification of an optimal threshold to define oliguria in critically ill patients: an observational study https://pubmed.ncbi.nlm.nih.gov/37254158/
    Editorial on MERCURI-2 in JAMA by Wolfgang Winkelmayer and Glenn Chertow https://jamanetwork.com/journals/jama/fullarticle/2852331

    Tubular Secretion

    Swapnil Spider Noire Amazon Prime
    Sophia Bernadoodle via Starlight Bernadoodle https://starlightbernedoodles.com
    Rahul Derry Girls on Netflix
    Vipin Tennis Cincinnati Open and the US Open. The death of the one handed backhand.
    Jay Slow Horses on Apple TV and Adults on Hulu
    Joel Silo season three. Mountain biking.
  • Freely Filtered, a NephJC Podcast

    NephJC Fall Pledge Drive 2026

    23/09/2026 | 3min
    Please give 🙏🏽 here: https://www.nephjc.com/news/2026/9/8/nephjc-fall-pledge-drive
  • Freely Filtered, a NephJC Podcast

    FF96 MAJESTY, or Mentor Two

    30/08/2026 | 1h 20min
    The Filtrate
    Joel Topf @kidney_boy
    Swapnil Hiremath @hswapnil.medsky.social
    Natalie Freidin Program director at Medical University of South Carolina
    AC @medpeedskidneys.bsky.social
    Special Guests
    Fernando Fervenza Professor of Medicine, The Mayo Clinic

    Editing
    Vip Vergues
    The Kidney Connection written and performed by Timothy Yau

    Show Notes
    MENTOR NephJC | NEJM | Freely Filtered episode 7
    PLA2r in 2009 M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy NEJM
    MAJESTY NephJC | NEJM Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
    Giuseppe Remuzzi discovers rituximab works in primary membranous. Rituximab for idiopathic membranous nephropathy The Lancet 2002
    Fervenza’s 15-person study of Rituximab treatment of idiopathic membranous nephropathy Kidney International 2008.
    Larry Beck’s NEJM PLA2r study M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy NEJM 2009
    2011 (not 2010) JASN paper where using banked serum from two prior rituximab studies in membranous nephropathy, Beck and Fervenza showed that declines in anti-PLA2R antibodies preceded reductions in proteinuria and predicted subsequent clinical remission, establishing the concept that immunologic remission precedes clinical remission. Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy PubMed
    The National Institute of Animal Health…a Fervenza fiction
    Robert A. Star, M.D. NIH
    Daniel C. Cattran, M.D. NephCure

    Tubular Secretions
    Swap do not go to see Mandalorian and Grogu or Supergirl
    AC doing nothing
    Natalie The Wealth Ladder by Nick Maggiulli (amazon)
    Fernando South Portugal and GlomCon Hawaii
    Joel The Boundary Waters Canoe Area
  • Freely Filtered, a NephJC Podcast

    FF95 The PUSH trial. Push it real good!

    23/08/2026 | 1h 6min
    The Filtrate
    Joel Topf@kidney_boy
    Vipin Verghese@vipvargh.bsky.social
    Nayan Arora @captainchloride
    Special Guests
    David Goldfarb Professor of Medicine, NYU (COI)
    Megan Prochaska Assistant professor of medicine at University of Chicago
    John Asplin Medical Director Consultant LithoLink (Twitter)

    Editing
    Anna Gaddy
    The Kidney Connection written and performed by Timothy Yau

    Show Notes
    Kidney Treks, University of Chicago. For medical students.
    The Push Trial: Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention NephJC Short | The Lancet
    Charlie Pak trial showing increased urine volume reduced risk of kidney stones. Evidence justifying a high fluid intake in treatment of nephrolithiasis PubMed
    The Borghi Trial: Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study PubMed
    Medical Management of Kidney Stones: AUA Guideline (2026)
    Weird little trial Asplin mentioned with amlodipine. But it was actually verapami. By Kemal Sarical: The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy PubMed
    Borghi’s other giant study in kidney stones: Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria NEJM
    The No Stone Trial: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence NephJC | NEJM
    Gary Curhan epidemiologic data from the Nurses Health Study and the Health Professionals Follow-up Study: Twenty-four-hour urine chemistries and the risk of kidney stones among women and men PubMed
    Gary Curhan epidemiologic data on sugar sweetened beverages and risk of kidney stones. Soda and other beverages and the risk of kidney stones PubMed
    Eric Topol’s tweet:

    NephJC in 2014 on the ACP Kidney Stone Guidelines NephJC
    Goldfarb’s scathing editorial on said guidelines, not on NephJC as I said but, on Fred Coe’s website at the University of Chicago. Link
    Tubular Secretions
    Nayan: Shrinking on Apple TV Wikipedia
    David: The deaths of Sonny Rollins (Wikipedia) and James Blood Ulmer (Wikipedia)
    Megan: Sri Lanka for travel (National Geographic)
    Vipin: Memory Eternal: Living with Grief as Orthodox Christians (Amazon)
    John: A History of Rock Music in 500 Songs (Link) Patty Smith’s memoir, Just Kids (Amazon)
    Joel: This is How You Lose The War by Amal El-Mohtar and Max Gladstone (Amazon) for the second time, and Acquired PodCast (Link)
  • Freely Filtered, a NephJC Podcast

    FF94 C3 Glomerulopathy with Carla Nester

    17/07/2026 | 1h 14min
    The Filtrate
    Joel Topf kidneyboy.bsky.social
    Swapnil Hiremath @hswapnil.medsky.social
    Natalie Freidin Program director at Medical University of South Carolina
    Sophia Ambruso @sophia_kidney
    AC @medpeedskidneys.bsky.social

    Special Guests
    Carla Nester, Professor of Medicine, Professor of Pediatrics, University of Iowa. Senior author of Valiant

    Editing
    Natalie Freidin
    The Kidney Connection written and performed by Timothy Yau

    Show Notes
    Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN NEJM | NephJC

    Tubular Secretions
    Swapnil: City of Last Chances by Adrian Tchaikovsky (Amazon)
    Natalie: Heated Rivalry, the books by Rachel Reid
    Carla: Rowing and gold fiber embroidery
    AC: Audiobooks, that are appropriate for children: The Giver and Tuck Everlasting
    Sophia: Greeking Out podcast and the Wheel of Time by Robert Jordan (Wikipedia)
    Joel: This is How You Lose The War by Amal El-Mohtar and Max Gladstone (Amazon)
Mais podcasts de Ciência
Sobre Freely Filtered, a NephJC Podcast
Twice monthly (aspirational) recap of the NephJC journal club. NephJC reviews the most important manuscripts which are driving nephrology forward and improving our understanding of the kidney.
Site de podcast

Ouça Freely Filtered, a NephJC Podcast, Radiolab e muitos outros podcasts de todo o mundo com o aplicativo o radio.net

Obtenha o aplicativo gratuito radio.net

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções
Aplicações
Social
v8.21.0 | © 2007-2026 radio.de GmbH
Generated: 10/3/2026 - 2:28:36 AM